783 related articles for article (PubMed ID: 28982721)
1. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
2. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
[TBL] [Abstract][Full Text] [Related]
3. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
[TBL] [Abstract][Full Text] [Related]
4. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
Chen X; Savarese G; Dahlström U; Lund LH; Fu M
Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
[TBL] [Abstract][Full Text] [Related]
7. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
8. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
9. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
[TBL] [Abstract][Full Text] [Related]
10. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T
JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331
[TBL] [Abstract][Full Text] [Related]
11. Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.
Gómez-Otero I; Ferrero-Gregori A; Varela Román A; Seijas Amigo J; Pascual-Figal DA; Delgado Jiménez J; Álvarez-García J; Fernández-Avilés F; Worner Diz F; Alonso-Pulpón L; Cinca J; Gónzalez-Juanatey JR;
Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):338-346. PubMed ID: 28011188
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
[No Abstract] [Full Text] [Related]
13. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.
Kapłon-Cieślicka A; Benson L; Chioncel O; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Ruschitzka F; Hage C; Drożdż J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Maggioni AP; Lund LH;
Eur J Heart Fail; 2022 Feb; 24(2):335-350. PubMed ID: 34962044
[TBL] [Abstract][Full Text] [Related]
14. Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
J Card Fail; 2021 Aug; 27(8):888-895. PubMed ID: 34364665
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
[TBL] [Abstract][Full Text] [Related]
16. Predictors and outcomes of heart failure with mid-range ejection fraction.
Bhambhani V; Kizer JR; Lima JAC; van der Harst P; Bahrami H; Nayor M; de Filippi CR; Enserro D; Blaha MJ; Cushman M; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Brouwers FP; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Levy D; Herrington DM; van Gilst WH; Bertoni AG; Larson MG; de Boer RA; Gottdiener JS; Shah SJ; Ho JE
Eur J Heart Fail; 2018 Apr; 20(4):651-659. PubMed ID: 29226491
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
18. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
[TBL] [Abstract][Full Text] [Related]
19. Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction.
Santas E; de la Espriella R; Palau P; Miñana G; Amiguet M; Sanchis J; Lupón J; Bayes-Genís A; Chorro FJ; Núñez Villota J
ESC Heart Fail; 2020 Jun; 7(3):1007-1014. PubMed ID: 32212327
[TBL] [Abstract][Full Text] [Related]
20. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
